Nureca Share Price

235.553.75 (1.62%)

Live
As On: 10 Jun, 2026, 11:05 AM IST
As On: 10 Jun, 2026, 11:05 AM IST

Sector: Hospitals & All...
Industry: Medical Equipment ...

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	232.20
High	238.50
Low	232.20
Prev Close	231.80
Volume	2,849
VWAP(₹)	236.41

Share Price	Value
Today/Current/Last	235.55236.00
Previous Day	231.80232.60

Nureca Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

Stocks in news: HCL Tech, Waaree Energies, HUL, Tata Power, Mahindra Logistics
News
These 7 healthcare stocks record their new 52-week lows, slip up to 32% in a month
News
Stock market update: Nifty IT index advances 0.05%
News
Nureca Limited Has Informed The Exchange Regarding No Change In The Aggregate Shareho..
Announcements

View all Nureca Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	36.42	41.83	40.06	36.75	33.73
Total Income Growth (%)	-12.93	4.43	9.01	8.94	20.73
Total Expenses	41.63	36.89	35.00	35.27	31.06
Total Expenses Growth (%)	12.85	5.39	-0.75	13.54	0.15
EBIT	-5.21	4.94	5.05	1.48	2.67
EBIT Growth (%)	-205.49	-2.26	241.72	-44.63	-
Profit after Tax (PAT)	-6.09	3.73	3.63	0.81	2.47
PAT Growth (%)	-263.15	2.92	346.25	-67.04	-
EBIT Margin (%)	-14.31	11.81	12.62	4.02	7.92
Net Profit Margin (%)	-16.73	8.93	9.06	2.21	7.31
Basic EPS (₹)	-6.45	3.91	3.63	0.81	2.47

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	36.47	41.93	40.22	36.92	33.75
Total Income Growth (%)	-13.02	4.23	8.96	9.39	17.48
Total Expenses	42.38	37.70	35.71	35.88	31.66
Total Expenses Growth (%)	12.41	5.59	-0.49	13.35	-2.40
EBIT	-5.91	4.23	4.52	1.04	2.09
EBIT Growth (%)	-239.88	-6.46	336.43	-50.53	-
Profit after Tax (PAT)	-6.63	3.23	3.14	0.55	2.07
PAT Growth (%)	-305.04	2.90	468.84	-73.36	-
EBIT Margin (%)	-16.21	10.08	11.23	2.80	6.20
Net Profit Margin (%)	-18.17	7.71	7.81	1.50	6.14
Basic EPS (₹)	-6.95	3.39	3.14	0.55	2.07

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	155.06	122.10	102.44	118.43	263.24
Total Revenue Growth (%)	27.00	19.19	-13.50	-55.01	21.72
Total Expenses	150.08	120.75	104.99	129.17	202.26
Total Expenses Growth (%)	24.29	15.02	-18.72	-36.14	31.39
Profit after Tax (PAT)	2.08	0.85	-1.79	-8.25	44.96
PAT Growth (%)	146.10	-	-	-118.35	-3.05
Operating Profit Margin (%)	4.26	2.33	-2.23	-9.24	24.15
Net Profit Margin (%)	1.41	0.77	-1.95	-7.41	17.59
Basic EPS (₹)	2.11	0.85	-1.79	-8.25	44.96

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	155.53	127.18	105.09	119.06	263.27
Total Revenue Growth (%)	22.29	21.03	-11.74	-54.77	21.80
Total Expenses	152.69	127.64	108.35	130.02	201.94
Total Expenses Growth (%)	19.63	17.80	-16.66	-35.61	31.42
Profit after Tax (PAT)	0.30	-0.67	-2.44	-8.42	45.31
PAT Growth (%)	-	-	-	-118.59	-2.63
Operating Profit Margin (%)	2.62	0.57	-2.97	-9.40	24.28
Net Profit Margin (%)	0.20	-0.58	-2.58	-7.52	17.73
Basic EPS (₹)	0.30	-0.67	-2.44	-8.42	45.31

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Slipping to Red
Company has posted a loss of Rs 6.09 cr in Mar 31, 2026 quarter after 3 consecutive quarter of profits. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 27.0% outperformed its 3 year CAGR of 9.3%. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	196.16	209.98	205.17	206.58	219.13
Total Assets Growth (%)	-6.58	2.34	-0.68	-5.73	17.97
Total Liabilities	15.40	15.69	12.05	11.70	15.93
Total Liabilities Growth (%)	-1.88	30.17	3.04	-26.58	-29.67
Total Equity	180.76	194.29	193.11	194.88	203.20
Total Equity Growth (%)	-6.96	0.61	-0.91	-4.09	24.59
Current Ratio (x)	8.32	15.32	20.77	21.00	16.85
Total Debt to Equity (x)	0.00	0.01	0.00	0.00	0.00
Contingent Liabilities	0.00	0.02	0.02	0.02	-

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	193.54	206.16	204.33	206.68	219.54
Total Assets Growth (%)	-6.12	0.90	-1.14	-5.86	18.11
Total Liabilities	16.38	13.68	11.47	11.42	15.79
Total Liabilities Growth (%)	19.74	19.27	0.44	-27.68	-30.10
Total Equity	177.16	192.48	192.86	195.26	203.74
Total Equity Growth (%)	-7.96	-0.20	-1.23	-4.16	24.77
Current Ratio (x)	7.47	17.66	21.58	21.36	17.01
Total Debt to Equity (x)	0.00	0.01	0.00	0.00	0.00
Contingent Liabilities	0.00	4.33	0.02	0.02	-

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	3.30	-19.08	-2.71	10.23	1.40
Net Cash used in Investing Activities	14.49	8.44	17.58	-16.46	-3.09
Net Cash flow from Financing Activities	-19.56	-0.17	-1.30	-1.51	-7.30
Net Cash Flow	-1.78	-10.82	13.56	-7.75	-8.99
Closing Cash & Cash Equivalent	1.46	3.24	14.06	0.50	8.25
Closing Cash & Cash Equivalent Growth (%)	-54.92	-76.95	2,690.08	-93.89	-52.16
Total Debt/ CFO (x)	0.22	-0.12	-0.18	0.01	0.05

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	0.32	-18.55	-3.00	12.05	1.83
Net Cash used in Investing Activities	16.50	8.56	17.84	-18.30	-3.37
Net Cash flow from Financing Activities	-18.61	-0.79	-1.28	-1.51	-7.30
Net Cash Flow	-1.79	-10.77	13.56	-7.76	-8.84
Closing Cash & Cash Equivalent	1.40	3.19	13.96	0.40	8.16
Closing Cash & Cash Equivalent Growth (%)	-56.18	-77.16	3,390.00	-95.10	-52.01
Total Debt/ CFO (x)	2.09	-0.08	-0.13	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	1.15	0.43	-0.92	-4.23	22.12
Return on Capital Employed (%)	3.43	1.29	-1.04	-5.20	29.83
Return on Assets (%)	1.06	0.40	-0.87	-3.99	20.51
Interest Coverage Ratio (x)	6.45	4.03	0.63	-17.56	85.30
Asset Turnover Ratio (x)	0.72	0.53	0.45	0.52	1.26
Price to Earnings (x)	95.24	250.00	-142.86	-36.50	30.30
Price to Book (x)	1.09	1.08	1.32	1.54	6.70
EV/EBITDA (x)	18.84	34.01	685.11	-29.03	20.22
EBITDA Margin (%)	5.63	4.46	0.33	-7.10	24.73

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	0.16	-0.34	-1.26	-4.31	22.23
Return on Capital Employed (%)	2.16	0.33	-1.43	-5.31	29.91
Return on Assets (%)	0.15	-0.32	-1.19	-4.07	20.63
Interest Coverage Ratio (x)	5.54	2.52	-1.23	-19.08	86.86
Asset Turnover Ratio (x)	0.74	0.56	0.46	0.53	1.26
Price to Earnings (x)	666.67	-322.58	-105.26	-35.71	30.12
Price to Book (x)	1.11	1.09	1.32	1.54	6.69
EV/EBITDA (x)	27.29	59.00	-370.99	-27.90	20.13
EBITDA Margin (%)	3.88	2.44	-0.59	-7.35	24.84

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Nureca Ltd	108.09	1.25	1.15	3.43	1.06	9.30	4.26	1.41	2.11	8.32	0.00	0.22
Poly Medicure	44.39	4.54	10.37	13.36	8.22	19.89	23.83	16.80	31.79	3.37	0.11	1.42
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance
- CHART
- TABLE
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
- Choose from Peers
  Choose from Stocks
NAME 1D 1W 1M 3M 1Y 3Y 5Y
Nureca Ltd Stock Performance 1.82 -13.00 -8.74 -19.12 -6.06 -27.94 -85.08
Poly Medicure Stock Performance -3.78 -7.71 -5.19 11.78 -43.62 44.42 23.88
Add More
All values in %
Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Nureca Ltd Stock Performance	1.82	-13.00	-8.74	-19.12	-6.06	-27.94	-85.08
Poly Medicure Stock Performance	-3.78	-7.71	-5.19	11.78	-43.62	44.42	23.88
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	64,97,176	68.09 %	3.12
Pledge	0	0.00 %	0.00
FII	26,608	0.28 %	0.20
DII	18,885	0.20 %	0.20
MF	0	0.00 %	0.00
Others	29,99,251	31.42 %	-3.52

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	68.09	64.97	64.97	64.33
Pledge	0.00	0.00	0.00	0.00
FII	0.28	0.08	0.07	0.07
DII	0.20	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	31.42	34.95	34.96	35.60

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 22, 2026
Board Meeting
Quarterly Results & Others
Jan 12, 2026
Board Meeting
Buy Back of Shares
Nov 25, 2025

Board Meetings

Announced on	Meeting on
May 22, 2026	May 29, 2026
Audited Results
Jan 12, 2026	Jan 17, 2026
Quarterly Results & Others
Nov 25, 2025	Nov 28, 2025
Buy Back of Shares
Nov 06, 2025	Nov 10, 2025
Buy Back of Shares
Oct 13, 2025	Oct 16, 2025
Quarterly Results & Others

Dividends
Announced on Ex-Date Dividend%
Feb 14, 2022 Feb 24, 2022 30%
Jun 16, 2021 Sep 21, 2021 20%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

Announced on	Ex-Date	Dividend%
Feb 14, 2022	Feb 24, 2022	30%
Jun 16, 2021	Sep 21, 2021	20%

AGM/EGM Meetings

Announced on	Meeting on
May 26, 2025	Jun 16, 2025
-
Feb 25, 2025	Apr 01, 2025
-
May 15, 2024	-
Book closure from Jul 12, 2024 to Jul 17, 2024
May 15, 2024	-
Book closure from Jul 12, 2024 to Jul 17, 2024
May 15, 2024	-
Book closure from Jul 12, 2024 to Jul 17, 2024

About Nureca

Nureca Ltd., incorporated in the year 2016, is a Small Cap company (having a market cap of Rs 221.18 Crore) operating in Hospitals & Allied Services sector.

Nureca Ltd. key Products/Revenue Segments include Health Care Products and Sale of services for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 36.42 Crore, down 12.93 % from last quarter Total Income of Rs 41.83 Crore and up 7.97 % from last year same quarter Total Income of Rs 33.73 Crore. Company has reported net profit after tax of Rs -6.09 Crore in latest quarter.

The company’s top management includes Mr.Saurabh Goyal, Mr.Aryan Goyal, Mr.Rajinder Sharma, Ms.Charu Singh, Ms.Ruchita Agarwal, Mr.Vijay Kumar Sharma, Mr.Naresh Gupta, Ms.Nishu Kansal. Company has B S R & Co. LLP as its auditors. As on 31-03-2026, the company has a total of .95 Crore shares outstanding.

Nureca Ltd Share Price Today is Rs. 235.55. On previous day, the Nureca Ltd Share Price (NSE) closed at Rs. 229.25, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 68.09% of the stake in Nureca Ltd shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Nureca Ltd stocks was 0.28% as compared to 0.08% in Dec 2025 with increase of 0.2%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.2% as compared to 0.0% in Dec 2025 with increase of 0.2%. Out of the total DII holdings in Nureca Ltd shares 0.0% was held by mutual funds. The rest including public held is 31.43%. Nureca Ltd stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Nureca Ltd Dividend: Ever since 2016, Nureca Ltd dividends has been paid out around 2 times. As on 10 Jun, 2026, 11:05 AM IST, The overall dividend yield for Nureca Ltd stands at 0.0%. The last dividend paid was on February 24, 2022 (Rs. 3.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 2.18.

Nureca Ltd Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 36.42 Cr. of sales and 12.93% of quarterly net loss, there have been multiple ups and downs in the Nureca Ltd stock prices in the past few weeks. For example, Nureca Ltd stock price on 2nd of June 2026 was around Rs. 237.25. Nureca Ltd share price now stands at an average of Rs. 235.55. Judging by last week's performance, stock is in down trend.

Nureca Ltd has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Nureca Ltd share.

Historical Prices and Performance:
Nureca Ltd, incorporated in 2016 is a Small Cap company (with a market cap of Rs. 221.18) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Nureca Ltd stock was 1.15%, 0.43%, -0.92%, -4.23% and 22.12% respectively.
The Nureca Ltd share gave a 3 year return of -39.8% as compared to Nifty 50 which gave a return of 25.2%.
Nureca Ltd announced 30.0% final dividend on February 24, 2022.

Key Metrics:
PE Ratio of Nureca Ltd is 106.18
Prices/Sales Ratio of Nureca Ltd is 1.34
Price/Book Ratio of Nureca Ltd is 1.22

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Nureca Ltd, major competitors and peers include Poly Medicure. As of Dec 2025, the dividend yield of Nureca Ltd stands at 0.0% while Poly Medicure stand at 0.24% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 106.18 and 1.22 respectively.

Leadership of Nureca Ltd :
Nishu Kansal is Co. Secretary & Compl. Officer
Naresh Gupta is Chief Financial Officer
Saurabh Goyal is Chairman & Managing Director
Aryan Goyal is WholeTime Director & CEO
Rajinder Sharma is Whole Time Director
Charu Singh is Independent Director
Ruchita Agarwal is Independent Director
Vijay Kumar Sharma is Independent Director

Industry

Medical Equipment & Accessories

Key Indices Listed On

-

Address

Office No. 101, Udyog Bhavan,1st Floor, Sonawala Lane,Goregaon East,Mumbai, Maharashtra - 400063

Contact

cs@nureca.com

http://www.nureca.com

PE Ratio(x)	108.09
EPS - TTM(₹)	2.18
MCap(₹ Cr.)	224.95
MCap Rank	30
PB Ratio(x)	1.22
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	343.00
52W Low(₹)	204.00
MCap/Sales	1.34
Beta(1 Month)	-
BV/Share(₹)	189.44

PE Ratio(x)	108.11
EPS - TTM(₹)	2.18
MCap(₹ Cr.)	225.19
MCap Rank	30
PB Ratio(x)	1.26
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	343.60
52W Low(₹)	200.10
MCap/Sales	1.34
Beta(1 Month)	-
BV/Share(₹)	189.44

1 Day	1.62%
1 Month	-19.65%
3 Months	-10.56%
1 Year	-16.63%
3 Years	-38.83%
5 Years	-84.46%

1 Day	1.46%
1 Month	-18.42%
3 Months	-10.69%
1 Year	-16.65%
3 Years	-38.28%
5 Years	-84.38%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Nureca Share Price

Key Metrics

Nureca Ltd share price insights

Nureca Ltd Share Price Returns

Nureca Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Nureca Ltd Top Searches

Corporate Actions

About Nureca

Executive Leadership

Auditors

FAQs about Nureca share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News